Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 1, 1996, Pages 64-67

  Nozawa, R ^a   Arai, M ^a   Kuruto, R ^a   Motohashi, T ^b   Masayasu, H ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; EBSELEN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; BODY WEIGHT; CANDIDA ALBICANS; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; MYCOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WEIGHT GAIN;

EID: 0029929550     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05879.x     Document Type: Article

References (23)

1. Akasaki, M., Ikeda, T., Numata, F., Kurebayashi, Y., Tsukada, W. (1989) Effect of ebselen (PZ-51) in liver failure induced by Propionibacterium acnes (P. acnes). In: Wendel, A. (ed.) Selenium in Biology and Medicine. Springer-Verlag, Heidelberg, pp 169-172
2. Cotgreave, I. A., Johansson, U., Westergren, G., Moldéus, P. W., Brattsand, R. (1988) The anti-inflammatory activity of Ebselen but not thiols in experimental alveolitis and bronchiolitis. Agents Actions 24: 313-319
3. Cotgreave, I. A., Duddy, S. K., Kass, G. E. N., Thompson, D., Moldéus, P. (1989) Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C? Biochem. Pharmacol. 38: 649-656
4. Fischer, H., Terlinden, R., Löhr, J. P., Römer, A. (1988) A novel biologically active selenoorganic compound VIII. Biotransformation of ebselen. Xenobiotica 18: 1347-1359
5. Henson, P. M., Johnston, R. B. (1987) Tissue injury in inflammation: oxidants, proteases and cationic proteins. J. Clin. Invest. 79: 669-675
6. Hoshida, S., Kuzuya, T , Nishida, M., Yamashita, N., Hori, M., Kamada, T., Tada, M. (1994) Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction. Am. J. Physiol. 267: H2342-H2347
7. Ichikawa, S., Omura, K., Katayama, T., Okamura, N., Ohtsuka, T., Ishibashi, S., Masayasu, H. (1987) Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen. J. Pharmacobiodyn. 10: 595-597
8. Kao, F.-T., Puck, T. T. (1974) Induction and isolation of auxotrophic mutants in mammalian cells. In: Prescott, D. M. (ed.) Methods in Cell Biology. Vol 8, Academic Press, San Diego, pp 23-39
9. Kurebayashi, Y., Tabuchi, Y., Akasaki, M. (1989) Gastric cytoprotection by ebselen against the injury induced by necrotizing agents in rats. Drug Res. 39: 250-253
10. Leurs, R., Timmerman, H., Bast, A. (1989) Inhibition of superoxide anion radical production by ebselen (PZ51) and its sulfur analogue (PZ25) in guinea pig alveolar macrophages. Biochem. Int. 18: 295-299
11. Matsui, T., Johsita, H., Asano, T., Tanaka, J. (1990) Effect of a free radical scavenger, ebselen, on cerebral ischemia. In: Krieglstein, J., Oberpichller, H. (eds) Pharmacology of Cerebral Ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 363-367
12. Müller, A., Cadenas, E , Graf, P., Sies, H. (1984) A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem. Pharmacol. 33: 3235-3239
13. Nathan, C. F., Root, R. K. (1977) Hydrogen peroxide release from mouse peritoneal macrophages. Dependence on sequential activation and triggering. J. Exp. Med. 146: 1648-1662
14. Niederau, C., Ude, K., Niederau, M., Lüthen, R., Strohmeyer, G., Ferrell, L. D., Grendell, J. H. (1991) Effects of the seleno-organic substance ebselen in two different models of acute pancreatitis. Pancreas 6: 282-290
15. Nozawa, R., Sekiguchi, R., Yokota, T. (1980) Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, and muramyl dipeptide of candidacidal activity of mouse macrophages. Cell. Immunol. 53: 116-124
16. Nozawa, R., Kato, H., Ito, T., Yokota, T. (1988) Identification and characterization of a differentiation antigen in human neutrophils and monocytes Blood 71: 1288-1294
17. Nozawa, R., Yokota, T., Fujimoto, T. (1989) Susceptibility of methicillin-resisiant Staphylococcus aureus to the selenium-containing compound 2-phenyl-1,2-benziso-selenazol-3(2H)-one (PZ51). Antimicrob. Agents Chemother. 33: 1388-1390
18. Parnham, M. J., Graf, E. (1987) Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem. Pharmacol. 36: 3095-3102
19. Parnham, M. J., Kindt, S. (1984) A novel biologically active selenoorganic compound III. Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem. Pharmacol. 33: 3247-3250
20. Schalkwijk, J., van den Berg, W B., van de Putte, L. B. A., Joosten, L. A. B (1986) An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthritis Rheum. 29: 532-538
21. Terlinden, R., Feige, M., Römer, A. (1988) Determination of the two major metabolites of ebselen in human plasma by high-performance liquid chromatographv. J. Chromatogr. 430: 438-442
22. Weiss, S. J., Lobuglio, A. F. (1982) Biology of disease. Phagocyte-generated oxygen metabolites in cellular injury. Lab. Invest. 47: 5-18
23. Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., Otter, R. (1984) A novel biologically active seleno-organic compound II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem. Pharmacol. 33: 3241-3245